U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
OZORALIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
OZORALIZUMAB [JAN]
Common Name English
ATN 103
Code English
Ozoralizumab [WHO-DD]
Common Name English
OZORALIZUMAB [USAN]
Common Name English
ozoralizumab [INN]
Common Name English
ATN-103
Code English
Code System Code Type Description
FDA UNII
05ZCK72TXZ
Created by admin on Sat Dec 16 17:52:25 GMT 2023 , Edited by admin on Sat Dec 16 17:52:25 GMT 2023
PRIMARY
CAS
1167985-17-2
Created by admin on Sat Dec 16 17:52:25 GMT 2023 , Edited by admin on Sat Dec 16 17:52:25 GMT 2023
PRIMARY
DRUG BANK
DB12014
Created by admin on Sat Dec 16 17:52:25 GMT 2023 , Edited by admin on Sat Dec 16 17:52:25 GMT 2023
PRIMARY
WIKIPEDIA
OZORALIZUMAB
Created by admin on Sat Dec 16 17:52:25 GMT 2023 , Edited by admin on Sat Dec 16 17:52:25 GMT 2023
PRIMARY
USAN
XX-32
Created by admin on Sat Dec 16 17:52:25 GMT 2023 , Edited by admin on Sat Dec 16 17:52:25 GMT 2023
PRIMARY
ChEMBL
CHEMBL1743054
Created by admin on Sat Dec 16 17:52:25 GMT 2023 , Edited by admin on Sat Dec 16 17:52:25 GMT 2023
PRIMARY
INN
9369
Created by admin on Sat Dec 16 17:52:25 GMT 2023 , Edited by admin on Sat Dec 16 17:52:25 GMT 2023
PRIMARY
NCI_THESAURUS
C175183
Created by admin on Sat Dec 16 17:52:25 GMT 2023 , Edited by admin on Sat Dec 16 17:52:25 GMT 2023
PRIMARY
ACTIVE MOIETY
OZORALIZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966